創建日期 | 上市日期 | 董事長 | 總經理 |
---|---|---|---|
55/06/30 | 108/12/16 | VilhelmRobertWessman | PetarAntonovVazharov |
EPS | 本益比 | 股價淨值比 | 現金殖利率 |
4.85(Q2) | 13.91 | 4.25 | 1.38% |
實收資本額 | 已發行普通股 | ||
2,624,713,120 | 262,471,312 | ||
主要經營業務 | |||
西藥製造、零售 | |||
公司網址 | |||
lotuspharm.com.tw |
美時(1795) 月營收報表
年度/月份 | 營業收入(單位:千元) | 累計營業收入(單位:千元) | |||||
---|---|---|---|---|---|---|---|
單月營收 | 去年同月營收 | 單月月增率 | 單月年增率 | 累計營收 | 去年累計營收 | 累積年增率 | |
2023/08 | 1,184,833 | 996,806 | -48.2% | 18.9% | 12,438,490 | 8,112,261 | 53.3% |
2023/07 | 2,287,950 | 1,043,645 | 107.4% | 119.2% | 11,253,650 | 7,115,454 | 58.2% |
2023/06 | 1,103,110 | 1,040,734 | -16.5% | 6% | 8,965,703 | 6,071,809 | 47.7% |
2023/05 | 1,321,517 | 870,540 | -34.5% | 51.8% | 7,862,593 | 5,031,069 | 56.3% |
2023/04 | 2,017,216 | 999,151 | 41% | 101.9% | 6,541,075 | 4,160,529 | 57.2% |
2023/03 | 1,430,185 | 1,186,652 | 31.7% | 20.5% | 4,523,860 | 3,161,377 | 43.1% |
2023/02 | 1,085,919 | 1,028,926 | -45.9% | 5.5% | 3,093,675 | 1,974,725 | 56.7% |
2023/01 | 2,007,756 | 945,800 | 58% | 112.3% | 2,007,756 | 945,800 | 112.3% |
2022/12 | 1,270,976 | 914,162 | 18.6% | 39% | 14,632,770 | 12,649,190 | 15.7% |
2022/11 | 1,071,324 | 986,367 | 29.2% | 8.6% | 13,361,800 | 11,700,910 | 14.2% |
2022/10 | 829,290 | 868,252 | -75.2% | -4.5% | 12,290,470 | 10,714,540 | 14.7% |
2022/09 | 3,348,921 | 1,012,862 | 236% | 230.6% | 11,461,180 | 9,846,286 | 16.4% |
2022/08 | 996,806 | 936,958 | -4.5% | 6.4% | 8,112,261 | 8,833,317 | -8.2% |
2022/07 | 1,043,645 | 1,107,853 | 0.3% | -5.8% | 7,115,448 | 7,896,359 | -9.9% |
2022/06 | 1,040,734 | 1,150,118 | 19.5% | -9.5% | 6,071,803 | 6,788,506 | -10.6% |
2022/05 | 870,540 | 1,156,527 | -12.9% | -24.7% | 5,031,069 | 5,638,389 | -10.8% |
2022/04 | 999,151 | 1,157,472 | -15.8% | -13.7% | 4,160,529 | 4,481,861 | -7.2% |
2022/03 | 1,186,652 | 1,100,414 | 15.3% | 7.8% | 3,161,377 | 3,324,389 | -4.9% |
2022/02 | 1,028,926 | 1,015,941 | 8.8% | 1.3% | 1,974,725 | 2,223,950 | -11.2% |
2022/01 | 945,800 | 1,208,009 | 3.5% | -21.7% | 945,800 | 1,208,009 | -21.7% |
2021/12 | 914,162 | 1,011,132 | -7.3% | -9.6% | 12,615,070 | 10,728,580 | 17.6% |
2021/11 | 986,367 | 957,236 | 13.6% | 3% | 11,700,910 | 9,578,170 | 22.2% |
2021/10 | 868,252 | 1,023,290 | -14.3% | -15.1% | 10,714,430 | 8,620,935 | 24.3% |
2021/09 | 1,012,862 | 1,020,621 | 8.1% | -0.8% | 9,846,179 | 7,597,645 | 29.6% |
2021/08 | 936,958 | 747,953 | -15.4% | 25.3% | 8,833,317 | 6,576,172 | 34.3% |
2021/07 | 1,107,853 | 1,116,873 | -3.7% | -0.8% | 7,896,359 | 5,828,219 | 35.5% |
2021/06 | 1,361,956 | 1,052,244 | 17.8% | 29.4% | 7,000,344 | 4,711,346 | 48.6% |
2021/05 | 1,156,527 | 860,254 | -0.1% | 34.4% | 5,638,389 | 3,685,053 | 53% |
2021/04 | 1,157,472 | 790,366 | 5.2% | 46.4% | 4,481,836 | 2,824,799 | 58.7% |
2021/03 | 1,100,414 | 698,813 | 8.3% | 57.5% | 3,324,364 | 2,034,433 | 63.4% |
2021/02 | 1,015,941 | 519,923 | -15.9% | 95.4% | 2,223,950 | 1,265,351 | 75.8% |
2021/01 | 1,208,009 | 745,428 | 19.5% | 62% | 1,208,009 | 745,428 | 62% |
2020/12 | 1,011,132 | 1,734,290 | 5.6% | -41.7% | 10,589,300 | 9,174,740 | 15.4% |
2020/11 | 957,236 | 728,066 | -6.4% | 31.5% | 9,578,170 | 7,514,127 | 27.5% |
2020/10 | 1,023,290 | 739,594 | 0.3% | 38.3% | 8,620,083 | 6,786,061 | 27% |
2020/09 | 1,020,621 | 607,743 | 36.5% | 67.9% | 7,596,793 | 6,046,466 | 25.6% |
美時(1795) 歷年營收季增率
年度/季別 | 營收季增率 | 近4季營收季增率 | 年度/季別 | 營收季增率 | 近4季營收季增率 |
---|---|---|---|---|---|
2023Q2 | -1.81% | 9.57% | 2020Q3 | 6.76% | 9.19% |
2023Q1 | 42.64% | 9.31% | 2020Q2 | 37.61% | 7.94% |
2022Q4 | -41.15% | 2.83% | 2020Q1 | -38.66% | -2.53% |
2022Q3 | 85.17% | 19.60% | 2019Q4 | 61.68% | 19.90% |
2022Q2 | -7.94% | -6.05% | 2019Q3 | 0.12% | 5.40% |
2022Q1 | 14.18% | -1.27% | 2019Q2 | -10.12% | 4.82% |
2021Q4 | -9.45% | -1.71% | 2019Q1 | 33.51% | 10.74% |
2021Q3 | -16.82% | 1.34% | 2018Q4 | 4.29% | 2.09% |
2021Q2 | 10.58% | 8.17% | 2018Q3 | -3.48% | -0.24% |
2021Q1 | 11.12% | 12.90% | 2018Q2 | 8.06% | 0.57% |
2020Q4 | 3.68% | -1.96% | 2018Q1 | -0.16% | 1.25% |
評論0